Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

F. Teng · SciRah

Researcher profile · Semantic Scholar

F. Teng

Share profile

F. Teng — researcher profile on SciRah

h-index: 24
Works: 70
Citations: 2,787

Most-cited papers

PD-L1 expression in human cancers and its association with clinical outcomes
Xin Wang, F. Teng, L. Kong, Jin-Ming Yu
2016OncoTargets and Therapy724 citations Open access
Semantic Scholar
Predictive biomarkers in PD-1/PD-L1 checkpoint blockade immunotherapy.
Xiang-Jiao Meng, Zhao-Qin Huang, F. Teng, L. Xing +1 more
2015Cancer Treatment Reviews392 citations
Semantic Scholar
Progress and challenges of predictive biomarkers of anti PD-1/PD-L1 immunotherapy: A systematic review.
F. Teng, Xiang-Jiao Meng, L. Kong, Jin-Ming Yu
2018Cancer Letters224 citations
Semantic Scholar
Tumor infiltrating lymphocytes (TILs) before and after neoadjuvant chemoradiotherapy and its clinical utility for rectal cancer.
F. Teng, D. Mu, Xiang-Jiao Meng, L. Kong +4 more
2015American Journal of Cancer Research125 citations
Semantic Scholar
Tumor-infiltrating lymphocytes, forkhead box P3, programmed death ligand-1, and cytotoxic T lymphocyte-associated antigen-4 expressions before and after neoadjuvant chemoradiation in rectal cancer.
F. Teng, Xiang-Jiao Meng, L. Kong, D. Mu +4 more
2015Translational Research: The Journal of Laboratory and Clinical Medicine109 citations
Semantic Scholar
Radiotherapy combined with immune checkpoint blockade immunotherapy: Achievements and challenges.
F. Teng, L. Kong, Xiang-Jiao Meng, Jia Yang +1 more
2015Cancer Letters98 citations Open access
Semantic Scholar
Relationship between expression of PD-L1 and tumor angiogenesis, proliferation, and invasion in glioma
S. Xue, Man Hu, Peifeng Li, Ji Ma +6 more
2017OncoTarget96 citations Open access
Semantic Scholar
PD-1/PD-L1 checkpoint blockades in non-small cell lung cancer: New development and challenges.
Xiang-Jiao Meng, Yanli Liu, Jian-Jun Zhang, F. Teng +2 more
2017Cancer Letters87 citations
Semantic Scholar
Efficacy and Safety of Anti-PD-1 Plus Anlotinib in Patients With Advanced Non–Small-Cell Lung Cancer After Previous Systemic Treatment Failure—A Retrospective Study
Pei-Liang Wang, Xia Fang, Tian-Wen Yin, H. Tian +2 more
2021Frontiers in Oncology72 citations Open access
Semantic Scholar
DUSP1 induces apatinib resistance by activating the MAPK pathway in gastric cancer
F. Teng, Zhi-Yuan Xu, Jia-Hui Chen, Guo-Wei Zheng +5 more
2018Oncology Report67 citations Open access
Semantic Scholar
Radiation recall pneumonitis induced by PD-1/PD-L1 blockades: mechanisms and therapeutic implications
F. Teng, Min Li, Jin-Ming Yu
2020BMC Medicine66 citations Open access
Semantic Scholar
MR-guided radiation therapy: transformative technology and its role in the central nervous system.
Yue Cao, C. Tseng, J. Balter, F. Teng +2 more
2017Neuro-Oncology62 citations Open access
Semantic Scholar
Immune Microenvironment Differences Between Squamous and Non‐squamous Non–small‐cell Lung Cancer and Their Influence on the Prognosis
Xiang-Jiao Meng, Yong-Sheng Gao, Lian Yang, Hai-Yan Jing +3 more
2019Clinical Lung Cancer59 citations
Semantic Scholar
Blood-tumor barrier opening changes in brain metastases from pre to one-month post radiation therapy.
F. Teng, C. Tsien, T. Lawrence, Yue Cao
2017Radiotherapy and Oncology58 citations
Semantic Scholar
Abscopal effect of metastatic pancreatic cancer after local radiotherapy and granulocyte-macrophage colony-stimulating factor therapy
F. Shi, Xin Wang, F. Teng, L. Kong +1 more
2017Cancer Biology & Therapy52 citations Open access
Semantic Scholar
PD-1/PD-L1 blockades in non-small-cell lung cancer therapy
W. Jing, Miaomiao Li, Yan Zhang, F. Teng +3 more
2016OncoTargets and Therapy51 citations Open access
Semantic Scholar
Aqueous Huaier Extract Suppresses Gastric Cancer Metastasis and Epithelial to Mesenchymal Transition by Targeting Twist
Zhi-Yuan Xu, Guo-Wei Zheng, Yiping Wang, Chunli Zhang +4 more
2017Journal of Cancer46 citations Open access
Semantic Scholar
Expressions of CD8+TILs, PD-L1 and Foxp3+TILs in stage I NSCLC guiding adjuvant chemotherapy decisions
F. Teng, Xiang-Jiao Meng, Xin Wang, Ju-Peng Yuan +5 more
2016OncoTarget46 citations Open access
Semantic Scholar
eIF5A2 regulates the resistance of gastric cancer cells to cisplatin via induction of EMT.
Jian-Cheng Sun, Zhi-Yuan Xu, Hang Lv, Yiping Wang +8 more
2018American journal of translational research37 citations
Semantic Scholar
New strategy for monitoring targeted therapy: molecular imaging
F. Teng, Xue Meng, Xin-Dong Sun, Jin-Ming Yu
2013International Journal of Nanomedicine36 citations Open access
Semantic Scholar
The predictive effect of the systemic immune-inflammation index for patients with small-cell lung cancer.
Duoying Wang, D. Guo, F. Shi, Ying-Ming Zhu +4 more
2019Future Oncology32 citations
Semantic Scholar
Efficacy of single-site radiotherapy plus PD-1 inhibitors vs PD-1 inhibitors for oligometastatic non-small cell lung cancer
Pei-Liang Wang, Tian-Wen Yin, Kai-Kai Zhao, Jin-Ming Yu +1 more
2021Journal of Cancer Research and Clinical Oncology24 citations Open access
Semantic Scholar
The role of exosomes in tumour immunity under radiotherapy: eliciting abscopal effects?
Tian-Wen Yin, H. Xin, Jin-Ming Yu, F. Teng
2021Biomarker Research24 citations Open access
Semantic Scholar
Comparative study of clinicopathological characteristics and prognosis between combined and pure small cell lung cancer (SCLC) after surgical resection
Yiying Guo, Lin Yang, Li Liu, Jia-Cong Wei +5 more
2020Thoracic Cancer24 citations Open access
Semantic Scholar
Lymphopenia association with accelerated hyperfractionation and its effects on limited-stage small cell lung cancer patients' clinical outcomes.
Xin Wang, Jie Lu, F. Teng, Jin-Ming Yu
2019Annals of Translational Medicine23 citations Open access
Semantic Scholar
Metastatic location of extensive stage small-cell lung cancer: implications for thoracic radiation
Hua-Qi Zhang, L. Deng, Xin Wang, Duoying Wang +2 more
2019Journal of Cancer Research and Clinical Oncology21 citations Open access
Semantic Scholar
Adaptive boost target definition in high-risk head and neck cancer based on multi-imaging risk biomarkers
F. Teng, M. Aryal, Jae Y. Lee, Choonik Lee +5 more
2017International Journal of Radiation Oncology, Biology, Physics18 citations Open access
Semantic Scholar
Clinicopathological features and prognostic analysis of 247 small cell lung cancer with limited stage after surgery.
Li Liu, Jia-Cong Wei, F. Teng, Yi-Xiang Zhu +7 more
2020Human Pathology16 citations Open access
Semantic Scholar
ARID1A serves as a receivable biomarker for the resistance to EGFR-TKIs in non-small cell lung cancer
Dan-Tong Sun, F. Teng, P. Xing, Jun-Ling Li
2021Molecular Medicine15 citations Open access
Semantic Scholar
Treatment-related lymphopenia impairs the treatment response of anti-PD-1 therapy in esophageal squamous cell carcinoma.
Tian-Wen Yin, Pei-Liang Wang, Jin-Ming Yu, F. Teng
2022International Immunopharmacology14 citations Open access
Semantic Scholar
The post-treatment neutrophil-to-lymphocyte ratio and changes in this ratio predict survival after treatment of stage III non-small-cell lung cancer with conventionally fractionated radiotherapy.
Duoying Wang, D. Guo, A. Li, Pei-Liang Wang +2 more
2020Future Oncology13 citations
Semantic Scholar
Primary tumor location is an important predictor of survival in pulmonary adenocarcinoma
Zhe Wang, Ming-Huan Li, F. Teng, L. Kong +1 more
2019Cancer Management and Research13 citations Open access
Semantic Scholar
PD-1 / PD-L 1 checkpoint blockades in non-small cell lung cancer : New development and challenges
Xiang-Jiao Meng, Yanli Liu, Jian-Jun Zhang, F. Teng +2 more
12 citations
Semantic Scholar
Expression and prognostic role of IKBKE and TBK1 in stage I non-small cell lung cancer
Xin Wang, F. Teng, Jie Lu, D. Mu +2 more
2019Cancer Management and Research7 citations Open access
Semantic Scholar
Optimum fractionation of radiation to combine PD‐1 blockade
F. Teng, Tian-Wen Yin, Xiao Ju, Pei-Liang Wang +2 more
2023MedComm5 citations Open access
Semantic Scholar
PD-L1 expression in human cancers and its association with clinical outcomes
Xin Wang, F. Teng, L. Kong, Jin-Ming Yu
20165 citations
Semantic Scholar
Apatinib to enhance chemosensitivity of gastric cancer to paciltaxel and 5-fluorouracil.
Xiang-Dong Cheng, Zhi-Yuan Xu, Jia-Hui Chen, Chunli Zhang +4 more
20174 citations
Semantic Scholar
Concurrent durvalumab plus chemoradiation therapy followed by durvalumab in Chinese patients with unresectable stage III non-small cell lung cancer: CRUISER study.
F. Teng, H. Ge, Bu-Hai Wang, Ya-Ping Xu +4 more
2023Journal of Clinical Oncology3 citations Open access
Semantic Scholar
Optimal Initial Time Point of Local Radiotherapy for Unresectable Lung Adenocarcinoma: A Retrospective Analysis on Overall Arrangement of Local Radiotherapy in Advanced Lung Adenocarcinoma
Xin-Ge Li, Jie Wang, X. Chang, Zhen-Hua Gao +3 more
2022Frontiers in Oncology3 citations Open access
Semantic Scholar
Clinical observation of radiotherapy combined with temozolomide in non-small cell lung cancer patients with brain metastases
F. Teng, Gui-Min Cui, Hong-Yun Shi, Miaoling Liu
20172 citations
Semantic Scholar
P64.03 A Phase II Single-Arm Trial of Apatinib as Maintenance Treatment Following First-Line Chemotherapy in Extensive Stage Small Cell Lung Cancer
F. Teng, P. Xing, Y. Wang, X. Hu +3 more
2021Journal of Thoracic Oncology1 citations Open access
Semantic Scholar
Anti-PD-1 With or Without Radiotherapy for Oligometastatic Non-Small Cell Lung Cancer.
F. Teng, P. Wang
2021International Journal of Radiation Oncology, Biology, Physics1 citations Open access
Semantic Scholar
P66.02 The Prognostic Implication of hes1 Protein Expression in Resected Small Cell Lung Cancers of 247 Cases
Lun-Xu Liu, Yong-Jun Guo, Xin Sun, J. Dong +5 more
2021Journal of Thoracic Oncology1 citations Open access
Semantic Scholar
CMAR_A_204924 6593..6602
Xin Wang, F. Teng, Jie Lu, D. Mu +2 more
20191 citations
Semantic Scholar
Anti-Tumour Treatment Predictive biomarkers in PD-1 / PD-L 1 checkpoint blockade immunotherapy
Xiang-Jiao Meng, Zhao-Qin Huang, F. Teng, Li-Gang Xing +1 more
20151 citations
Semantic Scholar
The Influence of Response to Initial Chemotherapy on Optimal Timing of Radiation Therapy Administration for Limited-Disease Small Cell Lung Cancer
F. Teng, J. Yue, L. Kong, J. Yu
20141 citations
Semantic Scholar
Reversion of erlotinib-acquired resistance twice by chemotherapy
F. Teng, Jian-Dong Zhang, Xue Meng, Jin-Ming Yu
2014Cancer Biology & Therapy1 citations Open access
Semantic Scholar
The influence of tumor distribution and extent of carcinomatosis in minimal residual disease after optimal primary cytoreductive surgery for epithelial ovarian cancer
R. Eisner, F. Teng, J. Berek
19931 citations
Semantic Scholar
Single cell RNA sequencing to reveal immune microenvironment in primary and brain metastatic lesion of non-small cell lung cancer.
F. Teng, Menglin Bai, Chao Liu, Xiaohui Li +3 more
2023Journal of Clinical Oncology0 citations Open access
Semantic Scholar
Revealing distinct immune landscape in EGFR mutant and EGFR wild type lung adenocarcinoma by using single-cell RNA sequencing.
Tian-Wen Yin, Chao Liu, Tian-Run Lei, Pei-Liang Wang +3 more
2023Journal of Clinical Oncology0 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

Jin-Ming Yu×32
Invite
Jin-Ming Yu — researcher profile on SciRah
L. Kong×11
Invite
L. Kong — researcher profile on SciRah
Xiang-Jiao Meng×11
Invite
Xiang-Jiao Meng — researcher profile on SciRah
Xin Wang×8
Invite
Xin Wang — researcher profile on SciRah

×7

Invite

Pei-Liang Wang — researcher profile on SciRah

Invite

D. Mu — researcher profile on SciRah

Tian-Wen Yin×6

Invite

Tian-Wen Yin — researcher profile on SciRah

Invite

L. Xing — researcher profile on SciRah

Invite

P. Xing — researcher profile on SciRah

Invite

Hui Zhu — researcher profile on SciRah

Jian-Bo Zhang×4

Invite

Jian-Bo Zhang — researcher profile on SciRah

Invite

Zhi-Yuan Xu — researcher profile on SciRah